Beschreibung
Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.
Figure 8
ChartSource Paper
Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.Cite This Figure
![Figure 8: Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.]() > Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." *Nutrients*, 2022. PMID: [35631156](https://pubmed.ncbi.nlm.nih.gov/35631156/)
<figure> <img src="" alt="Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients." /> <figcaption>Figure 8. Gut microbiota composition analysis from participants with diarrhea-predominant IBS receiving Lactiplantibacillus plantarum GTB1 supplementation for four weeks. Changes in bacterial taxa suggest the probiotic may modulate intestinal microbial balance in IBS-D patients.<br> Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631156/">35631156</a></figcaption> </figure>